Science News
from research organizations

Drug-dispensing Contact Lens

Date:
July 23, 2009
Source:
Children's Hospital Boston
Summary:
Taking eye drops multiple times a day can be difficult to do, and as little as 1 to 7 percent of the dose is actually absorbed by the eye. Now, researchers have developed special contact lenses that can gradually dispense a constant amount of medication to the eye, at adjustable rates.
Share:
       
FULL STORY

Taking eye drops multiple times a day can be difficult for patients to do, and because of blinking and tearing, as little as 1 to 7 percent of the dose is actually absorbed by the eye. Now, researchers led by Daniel Kohane, MD, PhD, director of the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston, have developed special contact lenses that can gradually dispense a constant amount of medication to the eye, at adjustable rates. 

Although other groups have developed drug-releasing contact lenses, none have been able to achieve a constant, steady release of substantial amounts of drug; typically, a burst of drug is delivered in the first few hours, followed by rapidly dwindling amounts that are too low to be therapeutic. Kohane, collaborator Joseph Ciolino, MD, of the Massachusetts Eye and Ear Infirmary, and colleagues at the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT) created a two-layer contact lens with an inner drug-bearing biodegradable polymer film known as PLGA. Both PLGA and pHEMA (used for the coating) have been well studied and are already approved for ocular use by the Food and Drug Administration.

In laboratory testing, the prototype lenses dispensed ciprofloxacin (an antibiotic often used in eyedrops) for 30 days, the longest duration for which contact lenses are currently approved by the FDA; in some tests, the lenses continued releasing drug for up to 100 days. The amounts dispensed were sufficient to kill pathogens in a laboratory assay.

Kohane and Ciolino see applications in conditions such as glaucoma and dry-eye which require frequent daily eye drops. They have begun to test the lens in animals and plan to begin human testing as soon as possible. The technology recently won the Life Sciences track in MIT's 100K Entrepreneurship Competition.

The study was supported by the National Institute of General Medical Sciences at the National Institutes of Health, a Fight for Sight Grant-in-Aid, a Center for Integration of Medicine and Innovative Technology/Johnson & Johnson Young Investigator Award and the Boston KPro Fund, Massachusetts Eye and Ear Infirmary.

.


Story Source:

The above post is reprinted from materials provided by Children's Hospital Boston. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ciolino et al. A Drug-Eluting Contact Lens. Investigative Ophthalmology & Visual Science, 2009; 50 (7): 3346 DOI: 10.1167/iovs.08-2826

Cite This Page:

Children's Hospital Boston. "Drug-dispensing Contact Lens." ScienceDaily. ScienceDaily, 23 July 2009. <www.sciencedaily.com/releases/2009/07/090721111535.htm>.
Children's Hospital Boston. (2009, July 23). Drug-dispensing Contact Lens. ScienceDaily. Retrieved July 5, 2015 from www.sciencedaily.com/releases/2009/07/090721111535.htm
Children's Hospital Boston. "Drug-dispensing Contact Lens." ScienceDaily. www.sciencedaily.com/releases/2009/07/090721111535.htm (accessed July 5, 2015).

Share This Page: